IL-2 is a key
cytokine during proliferation and activation of T lymphocytes and functions as an auto- and paracrine
growth factor. Regardless of activating effects on T lymphocytes, the absence of
IL-2 has been linked to the development of autoimmune pathology in mice and humans.
Systemic lupus erythematosus (SLE) is a multifactorial
autoimmune disease and characterized by dysregulation of lymphocyte function,
transcription factor and
cytokine expression, and antigen presentation. Reduced
IL-2 expression is a hallmark of SLE T lymphocytes and results in decreased numbers of regulatory T lymphocytes which play an important role in preventing autoimmunity. Reduced
IL-2 expression was linked to overproduction of the transcription regulatory factor
cAMP-responsive element modulator (CREM)α in SLE T lymphocytes and subsequent CREMα binding to a CRE site within the
IL2 promoter (-180 CRE). In this study, we demonstrate the involvement of CREMα-mediated
IL2 silencing in T lymphocytes from SLE patients through a gene-wide
histone deacetylase 1-directed deacetylation of
histone H3K18 and
DNA methyltransferase 3a-directed
cytosine phosphate guanosine (CpG)-
DNA hypermethylation. For the first time, we provide direct evidence that CREMα mediates silencing of the
IL2 gene in SLE T cells though
histone deacetylation and CpG-DNA methylation.